Human Reproductive Technologies Market

Human Reproductive Technologies Market (Infertility: Drugs and Procedures & Contraceptives: Drugs and Devices) - Global Industry Analysis, Size, Procedures, Growth, Trends and Forecast, 2013 - 2019

  • Rep Id : TMRGL1876
  • Published On : Apr 2014
  • No. of Pages : 125
  • Category : Healthcare

Table of Contents
 
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.4 Research Methodology
1.5 List of Abbreviations
 
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Human Reproductive Technologies Market
2.2 Comparative Analysis: Global Human Reproductive Technologies Market, by Geography, 2012 & 2019 (Value %)
 
Chapter 3 Market Overview
3.1 Introduction and Market Definition
      3.1.1 Infertility Causative Factors
3.2 Market Drivers
      3.2.1 Delay in Conception
      3.2.2 Rise in the Number of Infertile Population
      3.2.3 Increasing Prevalence of Worldwide Obesity
      3.2.4 Lifestyle Hazards such as Smoking, Stress and Pollution
      3.2.5 Rising Prevalence of Unwanted Pregnancies and High Global Prevalence of Women with Unmet Contraceptive Needs
      3.2.6 Government and NGO Initiatives to Promote Contraceptive Products
      3.2.7 Implementation of the Patient Protection Act or the Affordable Care Act
3.3 Market Restraints
      3.3.1 Limited Insurance Coverage
      3.3.2 Economic and Social Factors
      3.3.3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
3.4 Market Opportunities
      3.4.1 Rise in Medical Tourism
      3.4.2 Government Support for Infertility Procedures
      3.4.3 Presence of Strong Contraceptives Pipeline
3.5 Porter’s Five Forces Analysis for the Global Human Reproductive Technologies Market
      3.5.1 Bargaining Power of Suppliers
      3.5.2 Bargaining Power of Buyers
      3.5.3 Threat of New Entrants
      3.5.4 Threat of Substitutes
      3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Human Reproductive Technologies Market, by Geography
 
Chapter 4 Global Human Reproduction Technologies Market, by Infertility Treatment
4.1 Overview
4.2 Infertility Drugs
      4.2.1 Global Infertility Drugs Market Revenue, by Brand, 2011 – 2019 (USD Million)
      4.2.2 Gonal-f
               4.2.2.1 Global Gonal-f Market Revenue, 2011 – 2019 (USD Million)
      4.2.3 Follistim AQ
              4.2.3.1 Global Follistim AQ Market Revenue, 2011 – 2019 (USD Million)
      4.2.4 AndroGel
              4.2.4.1 Global AndroGel Market Revenue, 2011 – 2019 (USD Million)
      4.2.5 Testim
              4.2.5.1 Global Testim Market Revenue, 2011 – 2019 (USD Million)
      4.2.6 Viagra
              4.2.6.1 Global Viagra Market Revenue, 2011 – 2019 (USD Million)
      4.2.7 Cialis
              4.2.7.1 Global Cialis Market Revenue, 2011 – 2019 (USD Million)
      4.2.8 Levitra/Staxyn
              4.2.8.1 Global Levitra/Staxyn Market Revenue, 2011 – 2019 (USD Million)
4.3 Infertility Treatment/Assisted Reproductive Technologies (ART)
      4.3.1 Global Infertility Treatment/ART Procedures Market Forecast, by Procedures, 2011 – 2019 (Number of Procedures)
      4.3.2 In Vitro Fertilization (IVF)
              4.3.2.1 Global IVF Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
      4.3.3 Intracytoplasmic Sperm Injection (ICSI)
              4.3.3.1 Global ICSI Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
      4.3.4 Zygote Intrafallopian Transfer (ZIFT)
              4.3.4.1 Global ZIFT Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
      4.3.5 Gamete Intrafallopian Transfer (GIFT)
              4.3.5.1 Global GIFT Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
      4.3.6 Intrauterine Insemination (IUI)
              4.3.6.1 Global IUI Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
 
Chapter 5 Global Human Reproductive Technologies Market, by Contraceptive Technologies
5.1 Overview
      5.1.1 Global Contraceptives Market Revenue, by Product Type, 2011 - 2019 (USD Million)
5.2 Contraceptive Drugs
      5.2.1 Global Contraceptive Drugs Market Revenue, by Type, 2011 – 2019 (USD Million)
      5.2.2 Oral Contraceptive Pills 
               5.2.2.1 Global Oral Contraceptive Pills Market Revenue, 2011 – 2019 (USD Million)
      5.2.3 Contraceptive Injectables
              5.2.3.1 Global Contraceptive Injectables Market Revenue, 2011 – 2019 (USD Million)
      5.2.4 Topical Contraceptives
              5.2.4.1 Global Topical Contraceptives Market Revenue, 2011 – 2019 (USD Million)
5.3 Contraceptive Devices
      5.3.1 Global Contraceptive Devices Market Revenue, by Type, 2011 – 2019 (USD Million)
      5.3.2 Male Contraceptive Devices (Male Condoms)
              5.3.2.1 Global Male Contraceptive Devices (Male Condoms) Market Revenue, 2011 – 2019 (USD Million)
      5.3.3 Female Contraceptive Devices
              5.3.3.1 Global Female Contraceptive Devices Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 6 Global Human Reproductive Technologies Market Revenue, by Geography
6.1 Overview
6.2 North America
      6.2.1 North America Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million)
      6.2.2 North America Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)
6.3 Europe
      6.3.1 Europe Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million)
      6.3.2 Europe Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
      6.4.1 Asia-Pacific Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million)
      6.4.2 Asia-Pacific Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
      6.5.1 RoW Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million)
      6.5.2 RoW Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)
 
Chapter 7 Recommendations
 
Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
      8.1.1 Company Overview
      8.1.2 Financial Overview
      8.1.3 Product Portfolio
      8.1.4 Business Strategies
      8.1.5 Recent Developments
8.2 Actavis, Inc.
      8.2.1 Company Overview
      8.2.2 Financial Overview
      8.2.3 Product Portfolio
      8.2.4 Business Strategies
      8.2.5 Recent Developments
8.3 Bayer AG
      8.3.1 Company Overview
      8.3.2 Financial Overview
      8.3.3 Product Portfolio
      8.3.4 Business Strategies
      8.3.5 Recent Developments
8.4 Church & Dwight, Co. Inc.
      8.4.1 Company Profile
      8.4.2 Financial Overview
      8.4.3 Product Portfolio
      8.4.4 Business Strategies
      8.4.5 Recent Developments
8.5 Cook Medical, Inc.
      8.5.1 Company Overview      
      8.5.2 Product Portfolio
      8.5.3 Business Strategies
      8.5.4 Recent Developments
8.6 Ferring International Center S.A.
      8.6.1 Company Overview
      8.6.2 Product Portfolio
      8.6.3 Business Strategies
      8.6.4 Recent Developments
8.7 Johnson & Johnson
      8.7.1 Company Overview
      8.7.2 Financial Overview
      8.7.3 Product Portfolio
      8.7.4 Business Strategies
      8.7.5 Recent Developments
8.8 Merck & Co., Inc.
      8.8.1 Company Overview
      8.8.2 Financial Overview
      8.8.3 Product Portfolio
      8.8.4 Business Strategies
      8.8.5 Recent Developments
8.9 Merck Serono
      8.9.1 Company Overview
      8.9.2 Financial Overview
      8.9.3 Product Portfolio
      8.9.4 Business Strategies
      8.9.5 Recent Developments
8.10 Pfizer, Inc.
      8.10.1 Company Overview
      8.10.2 Financial Overview
      8.10.3 Product Portfolio
      8.10.4 Business Strategies
      8.10.5 Recent Developments
8.11 Reckitt Benckiser Group plc
      8.11.1 Company Overview
      8.11.2 Financial Overview
      8.11.3 Product Portfolio
      8.11.4 Business Strategies
      8.11.5 Recent Developments
8.12 Teva Pharmaceutical Industries Ltd.
      8.12.1 Company Overview
      8.12.2 Financial Overview
      8.12.3 Product Portfolio
      8.12.4 Business Strategies
      8.12.5 Recent Developments
8.13 Warner Chilcott plc
      8.13.1 Company Overview
      8.13.2 Financial Overview      
      8.13.3 Product Portfolio
      8.13.4 Business Strategies
      8.13.5 Recent Developments

List of Tables
 
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Human Reproductive Technologies Market
TABLE 3 Side Effects Associated with the Use of Contraceptive Drugs and Devices
TABLE 4 Global Infertility Drugs Market Revenue, by Brand, 2011 – 2019 (USD Million)
TABLE 5 Global Infertility Treatment/ART Procedures Market Forecast, by Procedures, 2011 – 2019 (Number of Procedures)
TABLE 6 Global Contraceptives Market Revenue, by Product Type, 2011 - 2019 (USD Million)
TABLE 7 Global Contraceptive Drugs Market Revenue, by Type, 2011 – 2019 (USD Million)
TABLE 8 List of Latest Oral Contraceptive Pill Approvals, 2010 – 2012
TABLE 9 Global Contraceptive Devices Market Revenue, by Type, 2011 – 2019 (USD Million)
TABLE 10 North America Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 11 Europe Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 12 Asia-Pacific Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million)
TABLE 13 RoW Human Reproductive Technologies Market Revenue, by Technology, 2011 – 2019 (USD Million)

List of Figures
 
FIG. 1 Human Reproductive Technologies Market Segmentation
FIG. 2 Global Human Reproductive Technologies Market, by Infertility Drugs, 2011 - 2019 (USD Million)
FIG. 3 Global Human Reproductive Technologies Market, by Infertility Treatment Procedures, 2012 (Number of Procedures)
FIG. 4 Comparative Analysis: Global Human Reproductive Technologies Market, by Geography, 2012 & 2019 (Value %)
FIG. 5 Infertility Causative Factors: CDC, 2011 (%)
FIG. 6 Porter’s Five Forces Analysis: Global Human Reproductive Technologies Market
FIG. 7 Market Attractiveness Analysis: Global Human Reproductive Technologies Market, by Geography
FIG. 8 Global Gonal-f Market Revenue, 2011 – 2019 (USD Million)
FIG. 9 Global Follistim AQ Market Revenue, 2011 – 2019 (USD Million)
FIG. 10 Global AndroGel Market Revenue, 2011 – 2019 (USD Million)
FIG. 11 Global Testim Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Viagra Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Cialis Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global Levitra/Staxyn Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global IVF Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
FIG. 16 Global ICSI Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
FIG. 17 Global ZIFT Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
FIG. 18 Global GIFT Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
FIG. 19 Global IUI Procedures Market Forecast, 2011 – 2019 (Number of Procedures)
FIG. 20 Global Oral Contraceptive Pills Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 Global Contraceptive Injectables Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Global Topical Contraceptives Market Revenue, 2011 – 2019 (USD Million)
FIG. 23 Global Male Contraceptive Devices (Male Condoms) Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 Global Female Contraceptive Devices Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 North America Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)
FIG. 26 Europe Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)
FIG. 27 Asia-Pacific Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)
FIG. 28 RoW Human Reproductive Technologies Market Revenue, 2011 – 2019 (USD Million)
FIG. 29 Abbott Laboratories, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 30 Actavis, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 31 Bayer AG: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 32 Church & Dwight Co. Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 33 Johnson & Johnson: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 34 Merck & Co., Inc. (Pharmaceutical Division): Annual Revenue, 2010 – 2012 (USD Million)
FIG. 35 Merck Serono: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 36 Pfizer, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 37 Reckitt Benckiser Group plc: Annual Revenue, 2010 - 2012 (USD Million)
FIG. 38 Teva Pharmaceutical Industries Ltd.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 39 Warner Chilcott plc: Annual Revenue, 2010 - 2011 (USD Million)